FDA Clears CDC's Dengue MDx Test | GenomeWeb

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared for marketing a test for dengue virus developed by the US Centers for Disease Control and Prevention, CDC said today.

The test is the first FDA-approved molecular test for dengue and uses real-time PCR technology. Called the CDC DENV-1-4 Real Time RT PCR Assay, it can detect dengue within the first seven days after symptoms appear and can detect all four dengue virus types, CDC said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.